244 related articles for article (PubMed ID: 22712616)
1. Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation.
Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
Acta Ophthalmol; 2012 Aug; 90(5):e389-98. PubMed ID: 22712616
[TBL] [Abstract][Full Text] [Related]
2. Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy.
Liang CM; Tai MC; Chang YH; Chen YH; Chen CL; Lu DW; Chen JT
Acta Ophthalmol; 2011 Sep; 89(6):e505-14. PubMed ID: 21457483
[TBL] [Abstract][Full Text] [Related]
3. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells.
Bagheri A; Soheili ZS; Ahmadieh H; Samiei S; Sheibani N; Astaneh SD; Kanavi MR; Mohammadian A
Mol Vis; 2015; 21():378-90. PubMed ID: 25883524
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cell-mediated collagen gel contraction in human retinal pigment epithelium cells by vascular endothelial growth factor compared with transforming growth factor-β2.
Ma J; Zhang Q; Moe MC; Zhu T
Clin Exp Ophthalmol; 2012; 40(1):e76-86. PubMed ID: 21668782
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition-like phenotypic changes of retinal pigment epithelium induced by TGF-β are prevented by PPAR-γ agonists.
Hatanaka H; Koizumi N; Okumura N; Kay EP; Mizuhara E; Hamuro J; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6955-63. PubMed ID: 22956604
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulation by bevacizumab in ARPE-19 human retinal pigment epithelial cells.
Kuo CN; Chen CY; Lai CH; Lai LJ; Wu PC; Hung CH; Chen CH
Mol Med Rep; 2012 Oct; 6(4):701-4. PubMed ID: 22798045
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells by an MRTF-A Inhibitor.
Kobayashi M; Tokuda K; Kobayashi Y; Yamashiro C; Uchi SH; Hatano M; Kimura K
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):528-537. PubMed ID: 30707754
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model.
Daftarian N; Baigy O; Suri F; Kanavi MR; Balagholi S; Afsar Aski S; Moghaddasi A; Nourinia R; Abtahi SH; Ahmadieh H
Exp Eye Res; 2021 Jul; 208():108622. PubMed ID: 34022176
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition.
Li H; Li M; Xu D; Zhao C; Liu G; Wang F
Biochem Biophys Res Commun; 2014 Mar; 446(1):347-51. PubMed ID: 24607896
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells.
Park GB; Kim D; Kim YS; Kim JW; Sun H; Roh KH; Yang JW; Hur DY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5162-73. PubMed ID: 26244291
[TBL] [Abstract][Full Text] [Related]
13. Placental growth factor promotes epithelial-mesenchymal transition-like changes in ARPE-19 cells under hypoxia.
Zhang Y; Zhao L; Wang L; Yang X; Zhou A; Wang J
Mol Vis; 2018; 24():340-352. PubMed ID: 29769799
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells.
Fuchshofer R; Yu AL; Teng HH; Strauss R; Kampik A; Welge-Lussen U
Exp Eye Res; 2009 May; 88(5):889-99. PubMed ID: 19118548
[TBL] [Abstract][Full Text] [Related]
15. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
Lee H; O'Meara SJ; O'Brien C; Kane R
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells.
Jiang CG; Lv L; Liu FR; Wang ZN; Na D; Li F; Li JB; Sun Z; Xu HM
Cytokine; 2013 Jan; 61(1):173-80. PubMed ID: 23073116
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab modulates the process of fibrosis in vitro.
Zhang M; Chu S; Zeng F; Xu H
Clin Exp Ophthalmol; 2015 Mar; 43(2):173-9. PubMed ID: 24995375
[TBL] [Abstract][Full Text] [Related]
18. Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells.
Wang Y; Bian ZM; Yu WZ; Yan Z; Chen WC; Li XX
Exp Eye Res; 2010 Aug; 91(2):135-42. PubMed ID: 20188089
[TBL] [Abstract][Full Text] [Related]
19. Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells.
Yuan Q; Wang L; Zhang F; Wang R; Fu X; Peng Z; Ning W; Hu G; Wang Z; Tao L
Pharmazie; 2011 Dec; 66(12):961-7. PubMed ID: 22312703
[TBL] [Abstract][Full Text] [Related]
20. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
Ayalasomayajula SP; Ashton P; Kompella UB
J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
